Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2014 Mar;252(3):367-74.
doi: 10.1007/s00417-013-2461-x. Epub 2013 Sep 8.

The price for reduced light toxicity: Do endoilluminator spectral filters decrease color contrast during Brilliant Blue G-assisted chromovitrectomy?

Affiliations
Observational Study

The price for reduced light toxicity: Do endoilluminator spectral filters decrease color contrast during Brilliant Blue G-assisted chromovitrectomy?

Paul B Henrich et al. Graefes Arch Clin Exp Ophthalmol. 2014 Mar.

Abstract

Background: Vitreoretinal surgeons have been slow to adopt the use of spectral filters for endoillumination to reduce retinal light toxicity. This study shows that spectral filters can be used without a loss in color contrast during brilliant blue G chromovitrectomy.

Methods: To evaluate the influence of intra operative spectral light filters on perceivable contrast during Brilliant Blue G chromovitrectomy, a prospective, observational clinical study was carried out on 59 consecutive Brilliant Blue G chromovitrectomy interventions in 59 patients admitted for macular holes, macular pucker or vitreomacular traction syndromes. Subsequent to peeling of the internal limiting membrane, six different illumination modes were enabled consecutively: mercury vapor, mercury vapor/xenon, and xenon followed by xenon combined with an amber, green or yellow spectral filter. Main outcome measure was the chromaticity spread between stained internal limiting membrane and unstained retina as a measure for the color contrast perceived by the human eye.

Results: Mean chromaticity scores were similar for all light sources: mercury vapor 7.97, mercury vapor/xenon 7.96 (p = 0.96), and xenon 7.41 (p = 0.55). Compared to xenon, the additional use of endoillumination spectral filters did not change contrast recognizability: Chromaticity scores were 9.38 for the amber filter (p = 0.13), 6.63 for the green and 7.02 for the yellow filter (p = 0.37 and 0.64, respectively). When comparing the different filters head-to-head, the amber filter was superior to the green filter (p = 0.03), while the yellow was intermediate and not significantly different from either the amber (p = 0.08) or the green filter (p = 0.51).

Conclusions: Color contrast perceptibility during Brilliant Blue G assisted chromovitrectomy is similar with mercury vapor, mercury vapor/xenon or xenon light sources. Spectral filters do not decrease color contrast recognizability. Head-to-head comparison shows a significant advantage for the amber over the green filter with respect to contrast generation, the yellow filter is intermediate. As spectral filters are known to greatly reduce retinal light toxicity, we suggest donor eye studies to validate whether the amber filter should be generally recommended for Brilliant Blue G chromovitrectomy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Blue line: Mercury vapor (a) and xenon (b) endoillumination relative spectral output. Pink line: Relative photopic eye response curve. Yellow line: Relative aphakic hazard [3]. The ordinate displays a decimal division, the abscissa the wavelength in nanometers
Fig. 2
Fig. 2
Blue line: xenon + green filter (a) xenon + yellow filter (b) and xenon + amber filter (c) endoillumination relative spectral output. Pink line: Relative photopic eye response curve. Yellow line: Relative aphakic hazard [3]. The ordinate displays a decimal division, the abscissa the wavelength in nanometers
Fig. 3
Fig. 3
Screenshot displaying the same region of the fundus with plotted regions of interest (ROIs; long arrow) under different lighting: mercury-vapor (a), mercury-vapor–xenon (b) and xenon (c). The border between the stained ILM and the unstained underlying retina can be clearly appreciated (short arrow)
Fig. 4
Fig. 4
Screenshot displaying the same region of the fundus with plotted regions of interest (ROIs; long arrow) under xenon lighting combined with Amber (a), green (b) and yellow spectral filters (c). The border between the stained ILM and the unstained underlying retina can be clearly appreciated (short arrow)
Fig. 5
Fig. 5
Mercury vapor, xenon–mercury and xenon light sources produce comparable contrasts in BBG chromovitrectomy. The use of intraoperative light filters also does not significantly alter BBG performance with respect to contrast formation. The ordinate displays the CIELAB score. The upper and lower margins of the boxes in this standard box-and-whisker diagram represent the 25th and the 75th, the central line inside the box the 50th percentile (median). The whiskers mark the minimum and the maximum, with some outliers plotted as small circles

Similar articles

Cited by

References

    1. Fuller D, Machemer R, Knighton RW. Retinal damage produced by intraocular fiber optic light. Am J Ophthalmol. 1978;85:519–537. - PubMed
    1. Costa Ede P, Rodrigues EB, Farah ME, Dib E, Penha F, Magalhaes O, Jr, Furlani BA, Lima Filho AA, de Miranda A, Maia M. Vital dyes and light sources for chromovitrectomy: Comparative assessment of osmolarity, pH, and spectrophotometry. Invest Ophthalmol Vis Sci. 2009;50:385–391. doi: 10.1167/iovs.08-2285. - DOI - PubMed
    1. van den Biesen PR, Berenschot T, Verdaasdonk RM, van Weelden H, van Norren D. Endoillumination during vitrectomy and phototoxicity thresholds. Br J Ophthalmol. 2000;84:1372–1375. doi: 10.1136/bjo.84.12.1372. - DOI - PMC - PubMed
    1. Meyers SM, Bonner RF. Yellow filter to decrease the risk of light damage to the retina during vitrectomy. Am J Ophthalmol. 1982;94:677. - PubMed
    1. Rodrigues EB, Meyer CH, Kroll P. Chromovitrectomy: A new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol. 2005;243:291–293. doi: 10.1007/s00417-004-0992-x. - DOI - PubMed

Publication types

MeSH terms